Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2024
As of Dec 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q4 FY2020
As of Dec 31, 2020
Q4 FY2019
As of Dec 31, 2019
Q4 FY2018
As of Dec 31, 2018
Q4 FY2017
As of Dec 31, 2017
Q4 FY2016
As of Dec 31, 2016
Q4 FY2015
As of Dec 31, 2015
ASSETS
CURRENT ASSETS:
Cash and cash equivalents
Short-term bank deposits
Marketable securities
Trade receivables (net of allowance for credit losses of $6 and $0 at December 31, 2023 and 2024, respectively)
Prepaid expenses and other current assets
Total current assets
LONG-TERM ASSETS:
Marketable securities
Property and equipment, net
Intangible assets, net
Goodwill
Other long-term assets
Deferred tax assets
Total long-term assets
TOTAL ASSETS
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES:
Trade payables
Employees and payroll accruals
Accrued expenses and other current liabilities
Convertible senior notes, net
Deferred revenues
Total current liabilities
LONG-TERM LIABILITIES:
Convertible senior notes, net
Deferred revenues
Other long-term liabilities
Total long-term liabilities
TOTAL LIABILITIES
SHAREHOLDERS' EQUITY:
Ordinary shares of NIS 0.01 par value – Authorized: 250,000,000 shares at December 31, 2023 and 2024; Issued and outstanding: 42,255,336 shares and 49,426,711 shares at December 31, 2023 and 2024, respectively
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total shareholders' equity
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support